Guest guest Posted April 9, 2011 Report Share Posted April 9, 2011 News 8 new results for hepatitis c New hepatitis C drugs pose many questions7 hours agoaidsmapEven before new hepatitis C drugs come to market later this year, a vast array of hepatitis C antivirals currently in clinical trials is opening up new horizons for treatment of hepatitis C, in a situation strongly reminiscent of the explosion of HIV ...See all stories on this topic » Compass Biotechnologies Inc (COBI: OB) announces its subsidiary company C ...PR Newswire (press release)The name change was a first step in a corporate re focusing that would allow the Hepatitis C project to continue as originally envisioned sheltered within C-Pharma Inc., and to allow its parent company Compass Biotechnology to take advantage of several ...See all stories on this topic » Racing family raises hepatitis C awarenessK-State CollegianWhat makes the program unique, however, is the underlying tone of hepatitis C awareness. The concept for the show began when her brother, , a semi-professional formula 2000 race car driver, reconnected with a high school friend on Facebook. ...See all stories on this topic » Telaprevir Increases Second-Phase Hepatitis C DeclineDoctors LoungeAnalysis of the kinetics of telaprevir treatment for hepatitis C virus shows a rapid second-phase viral decline, which may allow for shorter duration of treatment, according to a study published online March 7 in Hepatology. FRIDAY, April 8 (HealthDay ...See all stories on this topic » Desai legal fees leave little for ex-patientsLas Vegas Review-JournalDesai, who owned the medical testing facilities purported to be responsible for the 2007 hepatitis C outbreak in Las Vegas, is claiming to be too mentally diminished to stand trial due to a stroke and has sent to Lake's Crossing Center for the Mentally ...See all stories on this topic » Biotech Stock Mailbag: Hep C Stock WinnersTheStreet.com (blog)By Adam Feuerstein 04/08/11 - 07:00 AM EDT BOSTON (TheStreet) -- Trying to make sense of the rapidly changing field of hepatitis C drug research kicks off this week's Biotech Stock Mailbag. Evan R. emails, "It looks like Pharmasset(VRUS) was the big ...See all stories on this topic » The starting lineknox.VillageSoup.comEarly in 2008, Tim learned he had hepatitis C. The diagnosis was a shock and an embarrassment to my brother, who believed that he'd already atoned for his sin — intravenous drug use. In 1980, Tim had spent three months in an inpatient drug treatment ...See all stories on this topic » knox.VillageSoup.com Ahead of the Bell: Inhibitex shares tumbleBusinessWeekProceeds will be used for a mid-stage clinical trial for a potential chronic hepatitis C infection and research and development expenses tied to other development programs. Inhibitex also is conducting clinical testing of a potential shingles treatment ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.